Wednesday, 26 August 2026European Markets

EQVA Stock Bullish Momentum With A 9.62% Jump On Monday

Loading stream...

(VIANEWS) - The Market ended the session with EQVA (EQVA.OL) rising 9.62% to kr3.19 on Monday while Oslo Børs Benchmark Index_GI fell 0.46% to kr1,225.87.

About EQVA

Eqva ASA, a knowledge-based maritime company, primarily engages in the shipbuilding business worldwide. It operates in two segments, Shipbuilding Technology and Other. The company provides newbuilding, rebuilding, and service assignments on vessels for offshore oil production, renewable energy production, fishing, and fish farming for ship owners. It delivers technology for customers within the seafood, energy, and transport sectors. The company was formerly known as Havyard Group ASA and changed its name to Eqva ASA in November 2022. Eqva ASA was founded in 1999 and is headquartered in Fosnavåg, Norway.

Earnings Per Share

As for profitability, EQVA has a trailing twelve months EPS of kr-0.29.

Volatility

EQVA's last week, last month's, and last quarter's current intraday variation average was a negative 4.88%, a negative 0.73%, and a positive 3.46%.

EQVA's highest amplitude of average volatility was 4.88% (last week), 3.09% (last month), and 3.46% (last quarter).

Volume

Today's last reported volume for EQVA is 541 which is 97.08% below its average volume of 18574.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EQVA's stock is considered to be overbought (>=80).

More news about EQVA (EQVA.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com